To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0451 | Acc1 Inhibitor 1q |
Novel highly potent and selective acetyl-CoA carboxylase 1 (ACC1) inhibitor (hACC1: IC 50 =0.58nM, hACC2: IC 50 >10000nM)
More description
|
|
| DCC0450 | Ac-ats010-ke |
Novel Selective, irreversible, and Rapid Cell-Permeable Inhibitor of Human Caspase-3
More description
|
|
| DCC0449 | Ac-5sglcnac |
Novel, cell-permeable, potent O-GlcNAc transferase (OGT) inhibitor
More description
|
|
| DCC0448 | Ac4glcnalk |
Novel metabolic oligosaccharide engineering (MOE) reagent, being an efficient chemical tool to probe protein glycosylation
More description
|
|
| DCC0447 | Ac4galnalk |
Novel metabolic oligosaccharide engineering (MOE) reagent, being an efficient chemical tool to probe protein glycosylation
More description
|
|
| DCC0446 | Ac-430 |
Novel potent and specific inhibitor of janus kinase 2 (JAK2)
More description
|
|
| DCC0445 | Ac3az11 |
Novel potent and selective multidrug resistance-associated protein 1 (MRP1, ABCC1) modulator
More description
|
|
| DCC0444 | Ac-3933 |
Novel benzodiazepine receptor partial inverse agonist
More description
|
|
| DCC0443 | Ac36az9 |
Novel potent, nontoxic, and highly selective breast cancer resistance protein (BCRP) inhibitor
More description
|
|
| DCC0442 | Ac34fgalnaz |
Prodrug of 4FGalNAz to label a variety of proteins in mammalian cells without perturbing endogenous glycosylation pathways and primarily act as a substrate for O-GlcNAc transferase (OGT)
More description
|
|
| DCC0441 | Ac32az19 |
Novel potent, nontoxic, and highly selective breast cancer resistance protein (BCRP) inhibitor
More description
|
|
| DCC0440 | Ac2p36 |
Novel inhibitor of Mycobacterium tuberculosis (Mtb), selectively killing Mtb at acidic pH and potentiating the bactericidal activity of isoniazid, clofazimine, and diamide
More description
|
|
| DCC0439 | Ac2p20 |
Novel inhibitor of Mycobacterium tuberculosis (Mtb) growth at acidic pH, killing Mtb by selectively depleting free thiols at acidic pH
More description
|
|
| DCC0438 | ac-260584 Oxalate |
Orally bioavailable M(1) muscarinic receptor allosteric agonist improving cognitive performance in an animal model
More description
|
|
| DCC0437 | Ac22(az8)2 |
Novel potent, nontoxic, and highly selective breast cancer resistance protein (BCRP/ABCG2) inhibitor
More description
|
|
| DCC0436 | ac-216 |
Selective NPFF(1) receptor ligand
More description
|
|
| DCC0435 | Ac1nod4q |
Novel blocker of HOX antisense intergenic RNA (HOTAIR) by abrogating the scaffold interaction with EZH2
More description
|
|
| DCC0434 | Ac18az8 |
Novel potent, nontoxic, and highly selective breast cancer resistance protein (BCRP) inhibitor
More description
|
|
| DCC0433 | Ac[phe1,2,3,arg4,d-ala8]dynorphin A-(1–11)nh2 |
Novel potent and selective KOR antagonist, potentially stabilizing the bioactive conformation and enhancing its metabolic stability
More description
|
|
| DCC0432 | Abzi-1 |
Novel agonist of STING (stimulator of interferon genes) with enhanced binding to STING and cellular function
More description
|
|
| DCC0431 | Abtz-1 |
Inhibitor of protein synthesis with potent activity against multidrug-resistant Gram-positive bacterial strains
More description
|
|
| DCC0430 | Abt-925 |
Selective dopamine D3 receptor antagonist
More description
|
|
| DCC0429 | Abt-670 |
Orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction
More description
|
|
| DCC0428 | Abt-594 Tosylate |
Potent nicotinic acetylcholine receptor agonist
More description
|
|
| DCC0427 | Abt-546 Hydrochloride |
Hghly selective antagonist for endothelin ET A receptor
More description
|
|
| DCC0426 | Abt-472 |
Novel PARP inhibitor
More description
|
|
| DCC0425 | Abt-418 |
Agonist of neural nicotinic acetylcholine receptors
More description
|
|
| DCC0424 | Abt-239 Tartrate |
Potent and selective histamine H3 receptor antagonist
More description
|
|
| DCC0423 | Abrusoside A |
Natural hACE2 inhibitor with strong affinity for the exopeptidase site of hACE2
More description
|
|
| DCC0422 | Abrectorin |
Natural TMPRSS2 inhibitor
More description
|
|